Curbing the appetites and restoring the capacity for satisfaction: The impact of GLP-1 agonists on the reward circuitry.
作者信息
Krupa Anna Julia
机构信息
Department of Affective Disorders, Jagiellonian University Medical College, Kopernika St. 21a, 31-501, Krakow, Poland.
出版信息
Neurosci Appl. 2025 Mar 3;4:105512. doi: 10.1016/j.nsa.2025.105512. eCollection 2025.
Abstract
摘要
相似文献
1
Curbing the appetites and restoring the capacity for satisfaction: The impact of GLP-1 agonists on the reward circuitry.抑制食欲并恢复满足感：胰高血糖素样肽-1受体激动剂对奖赏回路的影响。
Neurosci Appl. 2025 Mar 3;4:105512. doi: 10.1016/j.nsa.2025.105512. eCollection 2025.
2
GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling.胰高血糖素样肽-1（GLP-1）受体激动剂司美格鲁肽可降低食欲，同时增强多巴胺奖赏信号。
Neurosci Appl. 2023 Nov 22;3:103925. doi: 10.1016/j.nsa.2023.103925. eCollection 2024.
3
Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.比较 10 种胰高血糖素样肽-1 受体激动剂作为二甲双胍的附加治疗在 2 型糖尿病患者中的疗效和安全性：系统评价。
Front Endocrinol (Lausanne). 2023 Aug 28;14:1244432. doi: 10.3389/fendo.2023.1244432. eCollection 2023.
4
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂（GLP-1 RAs）减肥效果的网状Meta分析的数量、质量及结果：一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
5
Anorgasmia following initiation of GLP-1 agonist.胰高血糖素样肽-1激动剂起始治疗后出现性高潮障碍。
Sex Med. 2025 Jul 15;13(3):qfaf047. doi: 10.1093/sexmed/qfaf047. eCollection 2025 Jun.
6
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol.胰高血糖素样肽-1（GLP-1）受体激动剂司美格鲁肽在治疗难治性阿片类物质使用障碍门诊患者中戒除非法和非处方阿片类药物的疗效：一项随机、双盲、安慰剂对照临床试验方案。
Res Sq. 2025 May 26:rs.3.rs-6666196. doi: 10.21203/rs.3.rs-6666196/v1.
7
Glucagon-like peptide-1 receptor agonists and alcohol use disorders: An emerging unexpected beneficial effect.胰高血糖素样肽-1受体激动剂与酒精使用障碍：一种新出现的意外有益作用。
Diabetes Obes Metab. 2025 Aug;27(8):4083-4091. doi: 10.1111/dom.16453. Epub 2025 May 13.
8
Psychiatric and psychological adverse effects associated with dulaglutide, semaglutide, and liraglutide: A vigibase study.与度拉糖肽、司美格鲁肽和利拉鲁肽相关的精神和心理不良反应：一项药物不良反应全球数据库研究
Clin Nutr. 2025 Aug;51:252-265. doi: 10.1016/j.clnu.2025.06.011. Epub 2025 Jun 23.
9
A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies.一项关于司美格鲁肽对临床前动物模型和细胞系研究中认知功能影响的系统评价。
Int J Mol Sci. 2024 May 2;25(9):4972. doi: 10.3390/ijms25094972.
10
Impact of GLP-1 receptor agonists on upper gastrointestinal endoscopy: an updated systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂对上消化道内镜检查的影响：一项更新的系统评价和荟萃分析。
Surg Endosc. 2025 Jul 9. doi: 10.1007/s00464-025-11962-4.
本文引用的文献
1
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking.一种内源性胰高血糖素样肽-1（GLP-1）回路作用于腹侧被盖区（VTA）的γ-氨基丁酸（GABA）能神经元，以调节中脑边缘多巴胺能神经元并减少可卡因觅求行为。
Sci Adv. 2025 Feb 28;11(9):eadr5051. doi: 10.1126/sciadv.adr5051. Epub 2025 Feb 26.
2
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®).胰高血糖素样肽-1 受体激动剂（GLP-1 RAs）与自杀：一项使用向世界卫生组织药物警戒数据库（VigiBase®）报告进行的复制研究。
J Affect Disord. 2025 Jan 15;369:922-927. doi: 10.1016/j.jad.2024.10.062. Epub 2024 Oct 19.
3
Insulin Resistance, Temperament and Personality Traits Are Associated with Anhedonia in a Transdiagnostic Sample.胰岛素抵抗、气质与人格特质与跨诊断样本中的快感缺乏有关。
Brain Sci. 2024 Aug 31;14(9):890. doi: 10.3390/brainsci14090890.
4
GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review.GLP-1 激动剂与自杀意念和行为风险：再次被指示混淆？一篇叙述性综述。
Eur Neuropsychopharmacol. 2024 Oct;87:29-34. doi: 10.1016/j.euroneuro.2024.07.001. Epub 2024 Jul 27.
5
Consolidating evidence on the role of insulin resistance in major depressive disorder.整合胰岛素抵抗在重度抑郁症中作用的证据。
Curr Opin Psychiatry. 2024 Jan 1;37(1):23-28. doi: 10.1097/YCO.0000000000000905. Epub 2023 Nov 9.
6
Impact of insulin and insulin resistance on brain dopamine signalling and reward processing - An underexplored mechanism in the pathophysiology of depression?胰岛素及胰岛素抵抗对脑多巴胺信号传导和奖赏处理的影响——抑郁症病理生理学中一个未被充分探索的机制？
Neurosci Biobehav Rev. 2023 Jun;149:105179. doi: 10.1016/j.neubiorev.2023.105179. Epub 2023 Apr 12.
7
Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol.胰高血糖素样肽-1能否成为奖赏系统相关疾病的治疗靶点？关于美味食物、滥用药物和酒精的研究的定性综合与系统评价分析
Front Behav Neurosci. 2021 Jan 18;14:614884. doi: 10.3389/fnbeh.2020.614884. eCollection 2020.
8
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.在人类中，胰高血糖素样肽-1受体激活会改变大脑奖励系统对美味食物预期和食用的反应。
Diabetes Obes Metab. 2015 Sep;17(9):878-86. doi: 10.1111/dom.12506. Epub 2015 Jul 22.
Zotero 插件